Journal Watch
Vaccines and Global Health: The Week in Review continues its weekly scanning of key peer-reviewed journals to identify and cite articles, commentary and editorials, books reviews and other content supporting our focu-s on vaccine ethics and policy. Journal Watch is not intended to be exhaustive, but indicative of themes and issues the Center is actively tracking. We selectively provide full text of some editorial and comment articles that are specifically relevant to our work. Successful access to some of the links provided may require subscription or other access arrangement unique to the publisher.
If you would like to suggest other journal titles to include in this service, please contact David Curry at: david.r.curry@centerforvaccineethicsandpolicy.org

BMC Public Health
http://bmcpublichealth.biomedcentral.com/articles
(Accessed 12 Feb 2022)

The impact of COVID-19 and associated measures on health, police, and non-government organisation service utilisation related to violence against women and children
Globally, concerns have been raised that the priority implementation of public health measures in response to COVID-19 may have unintended negative impacts on a variety of other health and wellbeing factors, i…
Authors: Nadia Butler, Zara Quigg, Isabelle Pearson, Zhamin Yelgezekova, Aasa Nihlén, Mark A. Bellis, Yongjie Yon, Jonathon Passmore, Isabel Yordi Aguirre and Heidi Stöckl
Citation: BMC Public Health 2022 22:288
Content type: Research
Published on: 12 February 2022

BMC Research Notes
http://www.biomedcentral.com/bmcresnotes/content
(Accessed 12 Feb 2022)

Global research alliance in infectious disease: a collaborative effort to combat infectious diseases through dissemination of portable sequencing
To disseminate the portable sequencer MinION in developing countries for the main purpose of battling infectious diseases, we found a consortium called Global Research Alliance in Infectious Diseases (GRAID). …
Authors: Lucky R. Runtuwene, Nuankanya Sathirapongsasuti, Raweewan Srisawat, Narumon Komalamisra, Josef S. B. Tuda, Arthur E. Mongan, Gabriel O. Aboge, Victoria Shabardina, Wojciech Makalowski, Dela Ria Nesti, Wayan T. Artama, Lan Anh Nguyen-Thi, Kiew-Lian Wan, Byoung-Kuk Na, William Hall, Arnab Pain…
Citation: BMC Research Notes 2022 15:44
Content type: Research note
Published on: 12 February 2022

Contemporary Clinical Trials
Volume 113 February 2022
https://www.sciencedirect.com/journal/contemporary-clinical-trials/vol/113/suppl/C

Research article Open access
Launching a comparative effectiveness adaptive platform trial of monoclonal antibodies for COVID-19 in 21 days
Erin K. McCreary, J. Ryan Bariola, Tami Minnier, Richard J. Wadas, … Derek C. Angus
Article 106652

Global Legal Monitor – Library of Congress/USA
https://www.loc.gov/collections/global-legal-monitor/
[Accessed 12 Feb 2022]

Article
Austria: General COVID-19 Vaccine Mandate Enters into Force
On February 5, 2022, a general COVID-19 vaccine mandate entered into force in Austria for every Austrian resident 18 years or older. No direct coercion will be used to enforce it, meaning no one will be imprisoned for noncompliance; only administrative fines will be imposed. The COVID-19 Mandatory Vaccination Act (Act) will be automatically repealed … Continue reading “Austria: General COVID-19 Vaccine Mandate Enters…
Contributor: Gesley, Jenny
Date: 2022-02-10

Globalization and Health
http://www.globalizationandhealth.com/
[Accessed 12 Feb 2022]

Vaccine nationalism will persist: global public goods need effective engagement of global citizens
Authors: Stuart J. Peacock
Content type: Debate
12 February 2022
Abstract
Covid-19 presents a unique opportunity to transform democratic engagement in the governance of global public goods. In this paper, I describe a global public goods framework and how it relates to Covid-19 vaccines, and summarize some of the global responses to Covid-19. I discuss some of the global threats to health and prosperity posed by the inequitable distribution of vaccines, and propose transformative thinking to democratically engage citizens in the governance of global public goods. In recent years, public-private partnerships and philanthropic organizations have successfully stepped in to help international organizations like the UN and WHO provide global public goods, but they are not democratically elected or publicly accountable. Global public goods are critical to addressing Covid-19, future pandemic preparedness, global health policy, health equity, and the unfolding climate crisis. To make us more resistant and resilient to future global health crises we need transformative thinking to democratically engage global citizens. We need to lay the foundations for a ‘global social contract’ on global public goods.

Health Economics, Policy and Law 
Volume 17 – Special Issue 1 – January 2022
https://www.cambridge.org/core/journals/health-economics-policy-and-law/latest-issue

SPECIAL ISSUE: Country Responses to the COVID-19 Pandemic
Articles analyzing country responses in Australia, New Zealand, Canada, U.S., Belgium, Netherlands, Sweden, France, Italy

Health Policy and Planning
Volume 37, Issue 2, February 2022
https://academic.oup.com/heapol/issue/37/2

ORIGINAL ARTICLES
Public finance of universal routine childhood immunization in India: district-level cost estimates
Emily Schueller, Arindam Nandi, Amit Summan, Susmita Chatterjee, Arindam Ray …
Health Policy and Planning, Volume 37, Issue 2, February 2022, Pages 200–208, https://doi.org/10.1093/heapol/czab114

Health Policy and Planning
Volume 37, Issue 2, February 2022
https://academic.oup.com/heapol/issue/37/2

COVID-19 Preparedness and Response Plans from 106 countries: a review from a health systems resilience perspective
Saqif Mustafa, Yu Zhang, Zandile Zibwowa, Redda Seifeldin, Louis Ako-Egbe …
Health Policy and Planning, Volume 37, Issue 2, February 2022, Pages 255–268, https://doi.org/10.1093/heapol/czab089

Health Policy and Planning
Volume 37, Issue 2, February 2022
https://academic.oup.com/heapol/issue/37/2

REVIEW
Understanding the complexity of demand-side determinants on vaccine uptake in sub-Saharan Africa
Phylisha G van Heemskerken, Catherine J Decouttere, Henk Broekhuizen, Nico J Vandaele
Health Policy and Planning, Volume 37, Issue 2, February 2022, Pages 281–291, https://doi.org/10.1093/heapol/czab139

Humanitarian Practice Network
https://odihpn.org/

Online Article
Embedding ethics in the practice of humanitarian innovation
by Ian McClelland and Matthew Hunt
20 January 2022

Immunity
Feb 08, 2022 Volume 55 Issue 2 p185-376
https://www.cell.com/immunity/current

Perspective
SARS-CoV-2 infections in children: Understanding diverse outcomes
Petter Brodin
Open Access
Brodin summarizes the current understanding of immune responses to SARS-CoV-2 infections in children and the possible explanations for the overall milder COVID-19 disease in young versus older individuals. To explain the combined observations to date, Brodin proposes an energy allocation perspective to explain mild disease, viral dynamics, and MIS-C in children and young people.

JAMA
February 8, 2022, Vol 327, No. 6, Pages 503-597
https://jamanetwork.com/journals/jama/currentissue

Caring for the Critically Ill Patient
Clinical Outcomes Among Patients With 1-Year Survival Following Intensive Care Unit Treatment for COVID-19
Hidde Heesakkers, MD; Johannes G. van der Hoeven, MD, PhD; Stijn Corsten, MD; et al.
free access has active quiz
JAMA. 2022;327(6):559-565. doi:10.1001/jama.2022.0040
This exploratory prospective cohort study assesses the occurrence of physical, mental, and cognitive symptoms among ICU patients in the Netherlands who survived COVID-19 at 1 year following hospitalization.

JAMA
February 8, 2022, Vol 327, No. 6, Pages 503-597
https://jamanetwork.com/journals/jama/currentissue

Research Letter
Characteristics and Outcomes of Hospitalized Patients in South Africa During the COVID-19 Omicron Wave Compared With Previous Waves
Caroline Maslo, MD, PhD; Richard Friedland, MD, BVSc; Mande Toubkin, RN, RM, Rpaeds; et al.
free access has active quiz
JAMA. 2022;327(6):583-584. doi:10.1001/jama.2021.24868
This study describes the characteristics and clinical outcomes of patients hospitalized in South Africa during the Omicron wave compared with the same variables from earlier COVID-19 waves.

JAMA
February 8, 2022, Vol 327, No. 6, Pages 503-597
https://jamanetwork.com/journals/jama/currentissue

US Insurer Spending on Ivermectin Prescriptions for COVID-19
Kao-Ping Chua, MD, PhD; Rena M. Conti, PhD; Nora V. Becker, MD, PhD
free access has active quiz
JAMA. 2022;327(6):584-587. doi:10.1001/jama.2021.24352
This study examines insurer coverage of ivermectin prescriptions for COVID-19 in the US.

JAMA Network
COVID-19 Update February 12, 2022

These articles on COVID-19 were published across the JAMA Network in the last week.

JAMA Pediatrics
February 2022, Vol 176, No. 2, Pages 115-212
https://jamanetwork.com/journals/jamapediatrics/currentissue

Research Letter
Association of Discrimination and Health Care Experiences With Incomplete Infant Vaccination During COVID-19
Heidi Preis, PhD; Marci Lobel, PhD; Brittain Mahaffey, PhD; et al.
free access has active quiz
JAMA Pediatr. 2022;176(2):196-198. doi:10.1001/jamapediatrics.2021.4710
This observational analysis explores how the COVID-19 pandemic contributed to a decrease in infant vaccinations.

JAMA Pediatrics
February 2022, Vol 176, No. 2, Pages 115-212
https://jamanetwork.com/journals/jamapediatrics/currentissue

Intention to Vaccinate Children Against COVID-19 Among Vaccinated and Unvaccinated US Parents
Madhura S. Rane, PhD; McKaylee M. Robertson, PhD; Drew A. Westmoreland, PhD; et al.
free access has active quiz
JAMA Pediatr. 2022;176(2):201-203. doi:10.1001/jamapediatrics.2021.5153
This study examines parental intention to vaccinate children against COVID-19 and related sociodemographic factors in a national sample of US parents.

JAMA Pediatrics
February 2022, Vol 176, No. 2, Pages 115-212
https://jamanetwork.com/journals/jamapediatrics/currentissue

State Laws Permitting Adolescent Consent to Human Papillomavirus Vaccination and Rates of Immunization
Ashlynn R. Torres, BA; Nicholaus P. Johnson, MPH; Mallory K. Ellingson, MPH; et al.
JAMA Pediatr. 2022;176(2):203-205. doi:10.1001/jamapediatrics.2021.4591
This national cohort study examines National Immunization Survey–Teen to assess the association of adolescents’ ability to consent to human papillomavirus vaccination without parental involvement with vaccination rates.

Journal of Community Health
Volume 47, issue 1, February 2022
https://link.springer.com/journal/10900/volumes-and-issues/47-1

Articles
A Multilevel Intervention to Increase HPV Vaccination among Asian American Adolescents
Authors (first, second and last of 9)
Grace X. Ma, Lin Zhu, Min Qi Wang
Content type: Original Paper
Open Access
Published: 07 July 2021
Pages: 9 – 16

Journal of Community Health
Volume 47, issue 1, February 2022
https://link.springer.com/journal/10900/volumes-and-issues/47-1

Parental Perspectives on Immunizations: Impact of the COVID-19 Pandemic on Childhood Vaccine Hesitancy
Authors (first, second and last of 5)
Kaidi He, Wendy J. Mack, Vikram Anand
Content type: Original Paper
Published: 23 July 2021
Pages: 39 – 52

Journal of Community Health
Volume 47, issue 1, February 2022
https://link.springer.com/journal/10900/volumes-and-issues/47-1

Increasing Human Papillomavirus Vaccination in a Federally Qualified Health Center Organization Using a Systems-Based Intervention Integrating EHR and Statewide Immunization Information System
Authors (first, second and last of 7)
Debra M. Vinci, Jessica Ryan, Rebecca McClain
Content type: Original Paper
Open Access
Published: 31 July 2021
Pages: 53 – 62

Journal of Community Health
Volume 47, issue 1, February 2022
https://link.springer.com/journal/10900/volumes-and-issues/47-1

Outcomes from the Use of Targeted Interventions to Increase Meningococcal Vaccination Rates in a Pediatric Clinic
Authors (first, second and last of 5)
Lindsay Podraza, Jayan Vasudevan, Meera Varman
Content type: Original Paper
Published: 13 August 2021
Pages: 87 – 93

The Lancet
Feb 12, 2022 Volume 399 Number 10325 p605-694
https://www.thelancet.com/journals/lancet/issue/current

Comment
Offline: Complacency threatens progress against COVID-19
Richard Horton
Hans Kluge, WHO’s Regional Director for Europe, has been reported as saying that European nations could soon be entering a “long period of tranquillity” as the pandemic abates. Pointing out that mortality from COVID-19 seemed to be plateauing, he suggested the continent was approaching a “plausible endgame” and an “enduring peace”. As WHO’s chief spokesperson for the 53 countries that make up his regional responsibility, Kluge was no doubt seeking to strike an optimistic and encouraging note. But it is disappointing that he took such a narrow geographical perspective about a global pandemic. His words promote a false reassurance that could breed complacency, even conceit…

The Lancet
Feb 12, 2022 Volume 399 Number 10325 p605-694
https://www.thelancet.com/journals/lancet/issue/current

Articles
Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis
Antimicrobial Resistance Collaborators
Open Access

The Lancet
Feb 12, 2022 Volume 399 Number 10325 p605-694
https://www.thelancet.com/journals/lancet/issue/current

Casirivimab and imdevimab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
RECOVERY Collaborative Group
Open Access

The Lancet
Feb 12, 2022 Volume 399 Number 10325 p605-694
https://www.thelancet.com/journals/lancet/issue/current

Seminar
Measles
Judith M Hübschen, Ionela Gouandjika-Vasilache, Julia Dina

Nature
Volume 602 Issue 7896, 10 February 2022
https://www.nature.com/nature/volumes/602/issues/7896

Editorial | 08 February 2022
Long COVID and kids: more research is urgently needed
Like adults, children can experience long COVID, but few studies of the condition include young people. That has to change.

Nature
Volume 602 Issue 7896, 10 February 2022
https://www.nature.com/nature/volumes/602/issues/7896

Editorial | 09 February 2022
Africa is bringing vaccine manufacturing home
A major milestone was reached last week when scientists in South Africa reproduced Moderna’s COVID-19 vaccine. COVID-19 patents must now be shared.

Nature
Volume 602 Issue 7896, 10 February 2022
https://www.nature.com/nature/volumes/602/issues/7896

Article | 22 December 2021 | Open Access
Enhanced fitness of SARS-CoV-2 variant of concern Alpha but not Beta
The Alpha variant of SARS-CoV-2 outcompetes progenitor SARS-CoV-2 in upper respiratory tract replication competition in vivo.
Lorenz Ulrich, Nico Joel Halwe, Charaf Benarafa

Nature
Volume 602 Issue 7896, 10 February 2022
https://www.nature.com/nature/volumes/602/issues/7896

Article | 22 December 2021 | Open Access
Local and systemic responses to SARS-CoV-2 infection in children and adults
Mechanisms explaining the milder clinical syndrome that is observed in children with SARS-CoV-2 infection.
Masahiro Yoshida, Kaylee B. Worlock, Kerstin B. Meyer

Nature Genetics
Volume 54 Issue 2, February 2022
https://www.nature.com/ng/volumes/54/issues/2

Editorial | 11 February 2022
Our genes, our microbes
In recent years, large-scale genomic studies have been performed in attempts to determine how genetic variation in the human host influences the gut microbiome. As microbiome traits are very heterogeneous, new analytical approaches are needed to move this field forward. By using genetic tools, there is a huge opportunity to enrich our understanding of the complex link between humans and our intimately associated microbial species.

Nature Genetics
Volume 54 Issue 2, February 2022
https://www.nature.com/ng/volumes/54/issues/2

Perspective | 03 February 2022
Challenges and future directions for studying effects of host genetics on the gut microbiome
This Perspective discusses the analytical issues concerning heterogeneity and power encountered in microbial genome-wide association studies and highlights potential future directions for genetic analysis of the microbiome.
Serena Sanna, Alexander Kurilshikov, Alexandra Zhernakova

New England Journal of Medicine
February 10, 2022 Vol. 386 No. 6
https://www.nejm.org/toc/nejm/medical-journal

Original Articles
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients A. Jayk Bernal and Others

New England Journal of Medicine
February 10, 2022 Vol. 386 No. 6
https://www.nejm.org/toc/nejm/medical-journal

Efficacy and Safety of NVX-CoV2373 in Adults in the United States and Mexico L.M. Dunkle and Others
NVX-CoV2373 is an adjuvanted, recombinant spike protein nanoparticle vaccine that was shown to have clinical efficacy for the prevention of coronavirus disease 2019 (Covid-19) in phase 2b–3 trials in the United Kingdom and South Africa, but its efficacy had not yet been tested in North America.

New England Journal of Medicine
February 10, 2022 Vol. 386 No. 6
https://www.nejm.org/toc/nejm/medical-journal

Editorials
Molnupiravir — A Step toward Orally Bioavailable Therapies for Covid-19 R. Whitley

PLoS Medicine
http://www.plosmedicine.org/
(Accessed 12 Feb 2022)

Information nudges for influenza vaccination: Evidence from a large-scale cluster-randomized controlled trial in Finland
Lauri Sääksvuori, Cornelia Betsch, Hanna Nohynek, Heini Salo, Jonas Sivelä, Robert Böhm
Research Article | published 09 Feb 2022 PLOS Medicine
https://doi.org/10.1371/journal.pmed.1003919

PLoS One
http://www.plosone.org/
[Accessed 12 Feb 2022]

Research Article
Perceptions of risk of SARS-CoV-2 transmission in social and educational activities by infectious diseases and general pediatric healthcare providers, a pre-vaccine risk perception cross-sectional survey
Andrew B. Janowski, Philip M. Polgreen, Susan E. Beekmann, Jason G. Newland
Research Article | published 11 Feb 2022 PLOS ONE
https://doi.org/10.1371/journal.pone.0263767

PLoS One
http://www.plosone.org/
[Accessed 12 Feb 2022]

Factors affecting intention to take COVID-19 vaccine among Pakistani University Students
Mosharop Hossian, Md Abdullah Saeed Khan, Anum Nazir, Mohammad Hayatun Nabi, Mehedi Hasan, Ramisha Maliha, Mohammad Ali Hossain, Md Utba Rashid, Nizwa Itrat, Mohammad Delwer Hossain Hawlader
Research Article | published 11 Feb 2022 PLOS ONE
https://doi.org/10.1371/journal.pone.0262305

PLoS One
http://www.plosone.org/
[Accessed 12 Feb 2022]

Attitudes towards influenza, and COVID-19 vaccines during the COVID-19 pandemic among a representative sample of the Jewish Israeli population
Yasmin Maor, Shaked Caspi
Research Article | published 11 Feb 2022 PLOS ONE
https://doi.org/10.1371/journal.pone.0255495

PLoS One
http://www.plosone.org/
[Accessed 12 Feb 2022]

A method for estimating the impact of new vaccine technologies on vaccination coverage rates
Ben Davis, Michael Krautmann, Pascale R. Leroueil
Research Article | published 10 Feb 2022 PLOS ONE
https://doi.org/10.1371/journal.pone.0263612

PLoS One
http://www.plosone.org/
[Accessed 12 Feb 2022]

Characterizing polarization in online vaccine discourse—A large-scale study
Bjarke Mønsted, Sune Lehmann
Research Article | published 09 Feb 2022 PLOS ONE
https://doi.org/10.1371/journal.pone.0263746

PLoS One
http://www.plosone.org/
[Accessed 12 Feb 2022]

Misinformation, believability, and vaccine acceptance over 40 countries: Takeaways from the initial phase of the COVID-19 infodemic
Karandeep Singh, Gabriel Lima, Meeyoung Cha, Chiyoung Cha, Juhi Kulshrestha, Yong-Yeol Ahn, Onur Varol
Research Article | published 09 Feb 2022 PLOS ONE
https://doi.org/10.1371/journal.pone.0263381

PLoS One
http://www.plosone.org/
[Accessed 12 Feb 2022]

The impact of the COVID-19 pandemic on scientific research in the life sciences
Massimo Riccaboni, Luca Verginer
Research Article | published 09 Feb 2022 PLOS ONE
https://doi.org/10.1371/journal.pone.0263001

PLoS One
http://www.plosone.org/
[Accessed 12 Feb 2022]

The impact of risk perceptions and belief in conspiracy theories on COVID-19 pandemic-related behaviours
Jack P. Hughes, Alexandros Efstratiou, Sara R. Komer, Lilli A. Baxter, Milica Vasiljevic, Ana C. Leite
Research Article | published 08 Feb 2022 PLOS ONE
https://doi.org/10.1371/journal.pone.0263716

PNAS – Proceedings of the National Academy of Sciences of the United States
January 11, 2022; vol. 119 no. 3
https://www.pnas.org/content/119/3

Biophysics and Computational Biology
Heterologous vaccination interventions to reduce pandemic morbidity and mortality: Modeling the US winter 2020 COVID-19 wave
Nathaniel Hupert, Daniela Marín-Hernández, Bo Gao, Ricardo Águas, and Douglas F. Nixon
PNAS January 18, 2022 119 (3) e2025448119; https://doi.org/10.1073/pnas.2025448119

PNAS – Proceedings of the National Academy of Sciences of the United States
January 11, 2022; vol. 119 no. 3
https://www.pnas.org/content/119/3

Psychological and Cognitive Sciences
Open Access
Politicians polarize and experts depolarize public support for COVID-19 management policies across countries
Alexandra Flores, Jennifer C. Cole, Stephan Dickert, Kimin Eom, Gabriela M. Jiga-Boy, Tehila Kogut, Riley Loria, Marcus Mayorga, Eric J. Pedersen, Beatriz Pereira, Enrico Rubaltelli, David K. Sherman, Paul Slovic, Daniel Västfjäll, and Leaf Van Boven
PNAS January 18, 2022 119 (3) e2117543119; https://doi.org/10.1073/pnas.2117543119

PNAS – Proceedings of the National Academy of Sciences of the United States
January 11, 2022; vol. 119 no. 3
https://www.pnas.org/content/119/3

Evolution
Open Access
Targeted vaccination and the speed of SARS-CoV-2 adaptation
Sylvain Gandon and Sébastien Lion
PNAS January 18, 2022 119 (3) e2110666119; https://doi.org/10.1073/pnas.2110666119

Public Health Reports
Volume 137 Issue 1, January/February 2022
https://journals.sagepub.com/toc/phrg/137/1

Commentary
Faith-Based Organizations and SARS-CoV-2 Vaccination: Challenges and Recommendations
Jeff Levin, PhD, MPH, Ellen L. Idler, PhD, Tyler J. VanderWeele, PhD
First Published October 25, 2021; pp. 11–16

Public Health Reports
Volume 137 Issue 1, January/February 2022
https://journals.sagepub.com/toc/phrg/137/1

Topical Review
Research Synthesis, HIV Prevention Response, and Public Health: CDC’s HIV/AIDS Prevention Research Synthesis Project
Linda J. Koenig, PhD, Cynthia M. Lyles, PhD, Darrel Higa, PhD, Mary M. Mullins, MSLS, Theresa A. Sipe, PhD, MPHfor the HIV/AIDS Prevention Research Synthesis Project
First Published February 26, 2021; pp. 32–47